• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA PERIPHERAL STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA PERIPHERAL STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number UNK SUPERA
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Myocardial Infarction (1969); Renal Failure (2041); Perforation of Vessels (2135); Stenosis (2263); Obstruction/Occlusion (2422); Respiratory Failure (2484); Vascular Dissection (3160); Embolism/Embolus (4438); Thrombosis/Thrombus (4440); Unspecified Tissue Injury (4559)
Event Date 12/01/2020
Event Type  Injury  
Manufacturer Narrative
B3: date of procedure is estimated d4: the udi is unknown due to the part/lot number was not provided.D6: date of implant is estimated the device was not returned for evaluation.A review of the lot history record of the reported lot could not be conducted because the part and lot number was not provided.The reported patient effects of embolization, myocardial infarction, renal failure, restenosis, thrombosis, occlusion, vessel dissection, vessel perforation and surgical intervention are listed in the supera peripheral stent system instructions for use as potential adverse events.A conclusive cause for the reported respiratory failure, renal failure, stenosis, embolism / embolus, vascular dissection, perforation of vessels, obstruction/ occlusion, thrombosis/ thrombus, myocardial infarction, unspecified tissue injury and the relationship to the product, if any, cannot be determined.The treatments appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.The additional patient effect of death referenced in b5 is captured under separate medwatch report.As multiple devices were captured in the pmcf report, additional reports were filed under manufacturing reference numbers (b)(4).Pmcf attachment rpt2131801 rev c titled: post-market clinical follow-up evaluation report peripheral self-expanding stentsna.
 
Event Description
It was reported through the pmcf report, that the supera stent may be related to the adverse patient effects of death, myocardial infarction, pulmonary complications, renal complications, access site complications, thrombosis, embolization, dissection, perforation, occlusion, re-stenosis, revascularization, unplanned amputation / surgical intervention and re-hospitalization.Details are listed in the attached report, titled post-market clinical follow-up evaluation report peripheral self-expanding stents please see the attached post market clinical follow up evaluation report for specific information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA PERIPHERAL STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key16812305
MDR Text Key313987903
Report Number2024168-2023-04322
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Other
Type of Report Initial
Report Date 04/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/25/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK SUPERA
Was Device Available for Evaluation? No
Date Manufacturer Received04/03/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization; Disability;
Patient Age71 YR
Patient SexMale
-
-